First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 3: Porcine islet product manufacturing and release testing criteria

Pretreatment of Donor Pigs With a Diet Rich in Soybean Oil Increases the Yield of Isolated Islets

(2014) G. Loganathan et al.   TRANSPLANTATION PROCEEDINGS

Comparison of porcine endogenous retroviruses infectious potential in supernatants of producer cells and in cocultures

(2014) Michael Rodrigues Costa et al.   XENOTRANSPLANTATION

Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand

(2014) Shaun Wynyard et al.   XENOTRANSPLANTATION

Specific Pathogen-Free Pig Herds also Free fromCampylobacter?

(2014) E. M. Kolstoe et al.   Zoonoses and Public Health

Islet isolation from adult designated pathogen-free pigs: use of the newer bovine nervous tissue-free enzymes and a revised donor selection strategy would improve the islet graft function

(2011) Sang-Man Jin et al.   XENOTRANSPLANTATION

Rapid Quantitative Assessment of the Pig Pancreas Biopsy Predicts Islet Yield

(2010) T. Anazawa et al.   TRANSPLANTATION PROCEEDINGS

Prolonged Survival of Microencapsulated Neonatal Porcine Islet Xenografts in Immune-Competent Mice without Antirejection Therapy

(2009) Tsunehiro Kobayashi et al.   CELL TRANSPLANTATION

Chapter 3: Pig islet product manufacturing and release testing

(2009) Gregory S. Korbutt   XENOTRANSPLANTATION

Chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses

(2009) Joachim Denner et al.   XENOTRANSPLANTATION